Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Additional Information (Detail)

v2.4.0.8
Summary of Significant Accounting Policies - Additional Information (Detail) (USD $)
6 Months Ended
Jun. 30, 2014
Dec. 31, 2013
Jun. 30, 2014
Stock Option [Member]
Jun. 30, 2014
Argus Neurooptics LLC [Member]
Mar. 17, 2014
Argus Neurooptics LLC [Member]
Accounting Policies [Line Items]          
Gain (Loss) on Sale of Assets and Asset Impairment Charges $ 400,000        
Long-term Investments, Total 250,000 0   250,000 250,000
Short-term Investments $ 295,000 $ 0 $ 243,000